Find your strongest 510(k) predicate in minutes.
AI-powered predicate analysis backed by 91K+ indexed 510(k) summaries, the full openFDA clearance history, FDA guidance documents, and semantic search. FDA Best Practices compliance scoring on every candidate.
No account required for the first analysis. Results in under 5 minutes.
DEVICE · K-XXXXXX
Predicate Intelligence Report
Generated for review · 25+ pages
Executive Summary
- Recommended predicate
- Pathway decision
Selection Strategy
- 91K+ semantic search
- Lineage 3 levels deep
Technical Evidence
- 8-dimension SE matrix
- Best Practices scorecard
Submission Framework
- Pathway + PCCP + eSTAR
- Action checklist
Built for health-tech teams navigating FDA clearance.
Startup founders
First 510(k) submission? Get expert-level predicate analysis in minutes, without a multi-week, $5,000+ engagement. Understand your regulatory landscape before you spend.
Regulatory affairs
Validate predicate selection with data-driven scoring, FDA Best Practices compliance, and ready-to-use 510(k) Summary text, whether you're doing the work in-house or working with an outside consultant. Save hours of manual research either way.
Consultants & advisors
Deliver predicate analysis to your clients faster. Use Keenr as your research engine while you focus on strategy and client relationships. White-label exports and multi-report plans coming soon.
Investors & advisors
Evaluate regulatory feasibility in minutes. Understand pathway risk, predicate strength, and competitive landscape before committing capital. Same report your portfolio companies will use, ready to share.
From device description to regulatory strategy in 4 steps.
Describe your device
Enter your device description and intended use. Optionally specify if it's an AI/ML device or a modification of your own cleared device.
We search 91K+ clearances
Hybrid search combines openFDA structured data with semantic similarity across the full 510(k) summary corpus. Cross-code discovery finds predicates keyword search misses.
AI evaluates each candidate
Our reasoning loop scores every candidate against FDA's 4 Best Practices criteria, runs an 8-dimension substantial equivalence comparison aligned with eSTAR, and traces predicate lineage chains up to 3 levels deep.
Get your report
Download a 25+ page branded PDF with predicate recommendation, lineage chains, pathway decision, and ready-to-use 510(k) Summary narrative. AI/ML reports run longer with PCCP, foundation model, and algorithm change sections.
Not just a database search.
Most predicate tools search by product code and sort by date. We do something fundamentally different.
FDA Best Practices aligned
Every predicate is scored against FDA's September 2023 guidance: well-established methods, safety performance, no unmitigated issues, no design-related recalls. You get a compliance scorecard, not just a list.
Semantic search across 91K+ submissions
We don't just match product codes. Our vector database embeds every 510(k) summary and finds semantically similar devices across ALL product codes — catching predicates keyword search misses entirely.
Predicate lineage chains
See who your predicate cited as THEIR predicate, and who they cited. Trace citation chains 3 levels deep from actual 510(k) summary text. Understand chain depth and risk before FDA asks.
AI/ML device depth, built in
Every report includes IMDRF SaMD risk classification, Predetermined Change Control Plan (PCCP) requirement assessment, and AI/ML-specific documentation guidance based on FDA's January 2025 AI-Enabled Device Software Functions guidance. Foundation-model disclosure tracking and algorithm-change precedent libraries are in development. No competitor in the AI-native regulatory space ships this depth today.
Regulatory pathway decision engine
Not just "510(k)" — we evaluate Traditional, Special, Abbreviated, De Novo, Breakthrough Device, and PMA pathways with specific eligibility reasoning, PCCP assessment, and pre-submission meeting recommendations.
Ready-to-use 510(k) Summary text
Get a multi-paragraph predicate selection narrative formatted per FDA guidance Section VI. Explains predicate choice, best practices compliance, and substantial equivalence basis. Copy, adapt, submit.
What this report does for your submission.
Twelve research outputs across the five areas of a 510(k): early-stage strategy your team, your consultant, or your institutional partner can build a submission around.
Accelerates Pathway Planning
Recommends a regulatory pathway with the reasoning behind it, comparing Traditional 510(k) against Abbreviated, De Novo, and Breakthrough Device for your device profile. Gives your team or consultant a defensible starting point.
Tests Product Classification
Tests whether the product code you're considering fits your device's technical features, and surfaces adjacent codes worth a closer look. Reduces the risk of building a submission on a misclassified code.
Strengthens Predicate Selection
Ranks predicate candidates on a 100-point scale using FDA's September 2023 Best Practices criteria. Produces a scored shortlist of the most defensible substantial-equivalence options, with the full scorecard visible for every candidate, ready for a regulatory consultant's review.
Strengthens Safety Vetting
Cross-checks every candidate against openFDA: MAUDE adverse-event counts (voluntary + mandatory) and design-related recall flags. Surfaces safety patterns worth investigating before your team or consultant builds the substantial-equivalence argument.
Uncovers Competitive Insights
Quantifies the clearance landscape for your product code (volume, average review time, recent activity), and tracks semantically adjacent codes for competitive devices a keyword search might miss.
Reduces Drafting Time
Produces a draft Predicate Selection Narrative aligned with FDA Section VI requirements. A working draft your team or consultant can adapt, not a finished submission.
Maps to eSTAR Template
Routes the device analysis to mandatory eSTAR sections: Section 4 (Device Description), Section 5 (Substantial Equivalence), Section 9 (Software Documentation), Section 12 (Performance Testing). Cuts the translation work between research and template inputs.
Clarifies Compliance Needs
Assesses whether your system likely requires the "Enhanced" software documentation level under FDA's guidance, and outlines the design specs, traceability matrices, and cybersecurity protocols reviewers typically expect.
Informs Engineering Investment
Produces a prioritized launch checklist: Pre-Submission meeting timing, multi-site validation with demographic stratification, human factors testing. Helps focus engineering and clinical investment on the work most likely to matter at FDA review.
Consolidates Regulatory Research
Compiles the FDA guidance documents most relevant to your device, each with a direct link and a one-sentence breakdown of how the framework applies.
Informs PCCP Strategy
Drafts a Predetermined Change Control Plan (PCCP) outline your team or consultant can develop with FDA. Reduces the risk of the cycle where every post-market algorithm update triggers a new submission.
Anticipates AI/ML Review Risks
Surfaces recurring AI/ML failure patterns from cleared devices, with suggested mitigation areas for acceptance criteria and demographic dataset tracking. Anticipates the issues that most often trigger FDA additional-information requests.
Pay per report. Or by the bundle.
$499 per single report, with 3-pack and 10-pack bundles for teams running multiple devices. Partner subscriptions add editable Word export and portfolio dashboards.
Built on FDA guidance.
The tool's predicate selection methodology is anchored in FDA's September 2023 "Best Practices for Selecting a Predicate Device" guidance, supported by the documents listed below. Every report cites the specific guidance informing each section.
- Primary Methodology Reference
Best Practices for Selecting a Predicate Device to Support a Premarket Notification [510(k)] Submission
September 2023PRIMARY METHODOLOGY REFERENCE. Defines the four best-practice criteria for predicate selection — (1) well-established methods, (2) postmarket safety performance, (3) no unmitigated safety issues, (4) no design-related recall — that drive the FDA Best Practices Scorecard in every report this tool generates.
Open on FDA.gov →
-
The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
July 2014Foundational SE-determination framework that the 2023 Best Practices guidance sits inside. Defines how indications, technological characteristics, and performance data combine to demonstrate substantial equivalence — the structure the SE Comparison table in this report follows.
Open on FDA.gov →
-
De Novo Classification Process (Evaluation of Automatic Class III Designation)
October 2021Pathway for novel, low-to-moderate risk devices without an adequate predicate.
Open on FDA.gov →
-
Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations
January 2025Lifecycle-management expectations and submission content for AI-enabled devices.
Open on FDA.gov →
-
Marketing Submission Recommendations for a Predetermined Change Control Plan for AI/ML-Enabled Device Software Functions
December 2024PCCP framework — how to pre-authorize planned algorithm changes without re-submitting.
Open on FDA.gov →
-
Breakthrough Devices Program
September 2023Expedited development and review for devices addressing life-threatening or irreversibly debilitating conditions.
Open on FDA.gov →
-
Clinical Decision Support Software
September 2022Criteria for when CDS software is / is not a regulated device under 21st Century Cures.
Open on FDA.gov →
-
Software as a Medical Device (SaMD): Clinical Evaluation
December 2017Framework for generating clinical evidence to support SaMD.
Open on FDA.gov →
-
Software as a Medical Device (SaMD): Possible Framework for Risk Categorization and Corresponding Considerations
September 2014 (IMDRF)IMDRF risk categorization (I–IV) referenced in the AI/ML assessment section.
Open on FDA.gov →
-
eSTAR Program
OngoingElectronic submission template mandatory for most 510(k) submissions. The eSTAR Mapping section aligns each analysis area to the corresponding eSTAR section.
Open on FDA.gov →
Frequently asked questions.
What is a 510(k) predicate device?
How accurate is the predicate recommendation?
What data sources do you use?
Can I use this for AI/ML medical devices?
How is this different from searching openFDA myself?
Is the report suitable for my 510(k) submission?
What does a Keenr report cost, and are there volume discounts?
Do you offer consultant or multi-report plans?
How often is the database updated?
Ready to find your predicate?
Get your 25+ page Predicate Intelligence Report in minutes.
This tool is for informational and research purposes only and does not constitute regulatory, legal, or professional advice. All analysis is AI-generated and should be reviewed by a qualified regulatory professional. Data sourced from openFDA and publicly available 510(k) clearance packages. Terms · Privacy · FDA.gov